Janus Henderson Group PLC Has $22.45 Million Position in HCP, Inc. (HCP)
Janus Henderson Group PLC boosted its position in HCP, Inc. (NYSE:HCP) by 375.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 869,314 shares of the real estate investment trust’s stock after buying an additional 686,610 shares during the period. Janus Henderson Group PLC owned approximately 0.19% of HCP worth $22,450,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of HCP. Resolution Capital Ltd grew its position in HCP by 118.1% in the 2nd quarter. Resolution Capital Ltd now owns 6,481,980 shares of the real estate investment trust’s stock valued at $167,365,000 after buying an additional 3,509,889 shares during the last quarter. AEW Capital Management L P grew its position in HCP by 131.4% in the 2nd quarter. AEW Capital Management L P now owns 4,928,900 shares of the real estate investment trust’s stock valued at $127,264,000 after buying an additional 2,798,600 shares during the last quarter. Brookfield Asset Management Inc. grew its position in HCP by 32.3% in the 1st quarter. Brookfield Asset Management Inc. now owns 7,641,262 shares of the real estate investment trust’s stock valued at $177,507,000 after buying an additional 1,866,537 shares during the last quarter. Russell Investments Group Ltd. grew its position in HCP by 108.6% in the 1st quarter. Russell Investments Group Ltd. now owns 2,762,845 shares of the real estate investment trust’s stock valued at $64,203,000 after buying an additional 1,438,692 shares during the last quarter. Finally, American Century Companies Inc. grew its position in HCP by 158.1% in the 2nd quarter. American Century Companies Inc. now owns 1,833,866 shares of the real estate investment trust’s stock valued at $47,350,000 after buying an additional 1,123,229 shares during the last quarter. Hedge funds and other institutional investors own 88.29% of the company’s stock.
A number of equities analysts recently weighed in on the stock. Morgan Stanley lifted their price objective on shares of HCP from $23.50 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, August 16th. Stifel Nicolaus set a $28.00 target price on shares of HCP and gave the stock a “buy” rating in a research report on Friday, August 3rd. Cantor Fitzgerald initiated coverage on shares of HCP in a research report on Tuesday, August 7th. They set a “neutral” rating and a $28.00 target price on the stock. Capital One Financial restated an “equal weight” rating on shares of HCP in a research report on Monday, July 23rd. Finally, ValuEngine upgraded shares of HCP from a “sell” rating to a “hold” rating in a research report on Thursday, July 5th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company. HCP presently has a consensus rating of “Hold” and an average price target of $26.25.
HCP (NYSE:HCP) last released its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by ($0.27). The firm had revenue of $469.60 million for the quarter, compared to analyst estimates of $463.94 million. HCP had a return on equity of 1.12% and a net margin of 3.39%. The company’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same period last year, the firm earned $0.48 EPS. analysts forecast that HCP, Inc. will post 1.82 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 21st. Stockholders of record on Wednesday, August 8th were paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 5.52%. The ex-dividend date of this dividend was Friday, August 3rd. HCP’s dividend payout ratio (DPR) is presently 75.90%.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: What is a Stop Order?
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.